The CD69-Myl9 system is reported to be involved in the pathogenesis of airway inflammation, polyp formation of eosinophilic rhinosinusitis (ECRS) patients, and inflammatory bowel diseases, such as ulcerative colitis and Crohn’s disease (17, 18). Here, CD69 is linked to inflammatory bowel disease.